head-and-neck-cancer

Documents about head-and-neck-cancer

• CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer#879264ClinicalTrials.gov
• Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer#883761ClinicalTrials.gov
• Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck#967915ClinicalTrials.gov
• Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.#1007105ClinicalTrials.gov
• Enteral Omega 3 During Radiotherapy to Improve the Quality of Life and Functionality of Head and Neck Cancer Patients#901491ClinicalTrials.gov
• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma#896679ClinicalTrials.gov
• Feasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer#904344ClinicalTrials.gov
• Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies#825981ClinicalTrials.gov
• Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma#865361ClinicalTrials.gov
• Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma#868837ClinicalTrials.gov
• RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck#883403ClinicalTrials.gov
• Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC#915277ClinicalTrials.gov
• Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer#968584ClinicalTrials.gov
• CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers#851780ClinicalTrials.gov
• PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer#860933ClinicalTrials.gov
• Intensive Nutrition Counselling in Patients With Head and Neck Cancer#1033412ClinicalTrials.gov
• Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma#852526ClinicalTrials.gov
• Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy#914596ClinicalTrials.gov
• Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck#838031ClinicalTrials.gov
• Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer#866739ClinicalTrials.gov
• Zalutumumab in Non-curable Patients With SCCHN#827007ClinicalTrials.gov
• Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer#825708ClinicalTrials.gov
• Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer#873977ClinicalTrials.gov
• Home-Based Photo-Biomodulation for Management of Lymphoedema and Radiation Fibrosis in Patients After Head and Neck Cancer: A Single-Arm Feasibility Trial#1033692ClinicalTrials.gov
• A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer#838885ClinicalTrials.gov
• IReC-Bio and IReC Registry#802823ClinicalTrials.gov
• Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients#895400ClinicalTrials.gov
• Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC#828581ClinicalTrials.gov
• TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers#879702ClinicalTrials.gov
• Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades#886266ClinicalTrials.gov
• A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer#888404ClinicalTrials.gov
• Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study#969239ClinicalTrials.gov
• A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer#1008620ClinicalTrials.gov
• Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer#811736ClinicalTrials.gov
• Chlorhexidine Gel Therapy for Cariogenic Oral Microflora#837238ClinicalTrials.gov
• Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients#1046820ClinicalTrials.gov
• Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology#979305ClinicalTrials.gov
• Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers#390930ClinicalTrials.gov
• Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients#1009137ClinicalTrials.gov
• Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia#968071ClinicalTrials.gov
• A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers#262004HAL (France)
• Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma#314351ClinicalTrials.gov
• A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer#463721ClinicalTrials.gov
• Chemo-embolization for Head and Neck Cancer#803937ClinicalTrials.gov
• A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma#837299ClinicalTrials.gov
• Tumoral Versus Luminal Microbiome in Head and Neck Squamous Cell Carcinoma#871421ClinicalTrials.gov
• Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy#890247ClinicalTrials.gov
• Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging#912044ClinicalTrials.gov
• Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma#1032141ClinicalTrials.gov
• A case report of radiotherapy for head and neck cancer in a pregnant woman: dosimetric optimization and in vivo dosimetry#353955HAL (France)